| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AVROBIO, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 125,000 | 10 Jun 2021 | Direct | ||
| Krystal Biotech, Inc. | Director | Stock Option (Right to Buy) | 5,000 | 30 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | 30 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 18:09 |
| KRYS | Krystal Biotech, Inc. | 30 Jun 2024 | 1 | $0 | 4 | Director | 01 Jul 2024, 19:32 |
| KRYS | Krystal Biotech, Inc. | 30 Jun 2023 | 1 | $0 | 4 | Director | 03 Jul 2023, 16:24 |
| KRYS | Krystal Biotech, Inc. | 30 Jun 2022 | 1 | $0 | 4 | Director | 01 Jul 2022, 16:09 |
| KRYS | Krystal Biotech, Inc. | 30 Jun 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 11:30 |
| AVRO | AVROBIO, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Chief Scientific Officer | 14 Jun 2021, 18:03 |